Novel transcript, antisense to ATXN2L (ENSG00000275807)

ENSG00000275807, also known as "novel transcript, antisense to ATXN2L," is annotated as a non-coding RNA gene that is transcribed antisense to the protein-coding ATXN2L locus[1]. There is currently no experimental evidence establishing its protein product, biological function, or role as a conventional therapeutic target such as a receptor, enzyme, transporter, or transcription factor[1]. Its classification as an antisense RNA implies a possible regulatory role, potentially in modulating the expression of ATXN2L or related genes, but this remains unproven and not well characterized in the literature[1]. This entry does not correspond to a well-defined, actionable drug target, nor is it a protein with a described molecular function. It is primarily a gene annotation arising from genomic/transcriptomic studies, and information about its structure, function, or disease relevance is currently lacking[1]. ATXN2L itself encodes a protein potentially involved in RNA metabolism, but the antisense transcript is distinct and should not be confused with the protein product of ATXN2L[2][7].

Other names

novel transcript antisense to ATXN2LENSG00000275807